Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacovigilance: methods, recent developments and future perspectives.

L Härmark1, A C van Grootheest

  • 1Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 's-Hertogenbosch, The Netherlands. l.harmark@lareb.nl

European Journal of Clinical Pharmacology
|June 5, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clindamycin-induced acute generalised exanthematous pustulosis: five cases and a review of the literature.

The Netherlands journal of medicine·2016
Same author

Drug-induced cerebellar ataxia: a systematic review.

CNS drugs·2014
Same author

Monitoring adverse events of vaccines against Mexican flu.

The International journal of risk & safety in medicine·2011
Same author

Pancreatitis associated with the use of itraconazole.

The Netherlands journal of medicine·2010
Same author

[Adverse events following vaccination reported to the Netherlands Pharmacovigilance Center Lareb in 2004-2006].

Nederlands tijdschrift voor geneeskunde·2008
Same author

[Bruxism as a side effect of serotonin re-uptake inhibitors].

Nederlands tijdschrift voor tandheelkunde·2007
Same journal

Efficacy and safety of Ensitrelvir in COVID-19 patients: a systematic review and meta-analysis with focus on viral clearance and RNA change.

European journal of clinical pharmacology·2026
Same journal

Comparing National Health Technology Assessment approaches and the new European Joint Clinical Assessment framework: The case of onco-hematological medicines.

European journal of clinical pharmacology·2026
Same journal

The efficacy of letrozole in the medical management of ectopic pregnancy: a systematic review and meta-analysis.

European journal of clinical pharmacology·2026
Same journal

Detection of intravenous drug physicochemical incompatibilities in clinical practice: e-Harvis compared to reference tools.

European journal of clinical pharmacology·2026
Same journal

Efficacy and safety of doravirine/islatravir for the treatment of HIV-1: a systematic review and meta-analysis of randomized controlled trials with GRADE assessment.

European journal of clinical pharmacology·2026
Same journal

Critical analysis of digitalis glycosides: declining use but increasing poison-center exposure cases for digitoxin.

European journal of clinical pharmacology·2026
See all related articles

Pharmacovigilance ensures drug safety through methods like spontaneous reporting and database studies. New regulatory and scientific approaches, including patient involvement, aim to strengthen drug safety monitoring.

Area of Science:

  • Pharmacovigilance and Drug Safety
  • Regulatory Science
  • Patient Safety

Background:

  • Pharmacovigilance is crucial for ensuring patient safety by detecting, assessing, and preventing adverse drug reactions.
  • Current methods for understanding drug side effects include spontaneous reporting, intensive monitoring, and database studies.
  • Advancements in regulatory and scientific approaches are enhancing pharmacovigilance.

Purpose of the Study:

  • To review and discuss key aspects of pharmacovigilance.
  • To explore new methodological developments in drug safety.

Main Methods:

  • Literature review of pharmacovigilance principles and practices.
  • Analysis of regulatory and scientific advancements in drug safety.

Related Experiment Videos

Main Results:

  • Pharmacovigilance relies on diverse data sources for adverse event detection.
  • Regulatory strategies like conditional approval and risk management plans are evolving.
  • Scientific advancements emphasize transparency and patient involvement to improve drug safety.

Conclusions:

  • Strengthening pharmacovigilance is essential for public health.
  • Integrating regulatory and scientific innovations can enhance drug safety monitoring.
  • Increased patient engagement is a key component of modern pharmacovigilance.